Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Dissemination of Strongyloides stercoralis in a patient with systemic lupus erythematosus after initiation of albendazole: a case report | Journal of Medical Case Reports BioMed Central Open Access Case report Dissemination of Strongyloides stercoralis in a patient with systemic lupus erythematosus after initiation of albendazole a case report Catherine J Hunter 1 Mikael Petrosyan2 and Morris Asch1 Address 1Harbor UCLA Medical Center W Carson Street Department of Surgery Torrance CA 90502 USA and 2University of Southern California Keck School of Medicine North State Street Los Angeles CA 90033 USA Email Catherine J Hunter - Mikael Petrosyan - mpetrosyan@ Morris Asch - chunter@ Corresponding author Published 14 May 2008 Received 16 January 2008 Journal of Medical Case Reports 2008 2 156 doi l752-l947-2-156 Accepted 14 May 2008 This article is available from http content 2 l l56 2008 Hunter et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Introduction Strongyloides stercoralis infection affects hundreds of millions of people worldwide. As immigration rates and international travel increase so does the number of cases of strongyloidiasis in the United States. Although described both in immigrant and in immunosuppressed populations hyperinfection and dissemination of S. stercoralis following the initiation of antiparasitic medication is a previously unreported phenomenon. Case presentation Here we describe the case of a 38-year-old immunocompromised woman with systemic lupus erythematosus who developed disseminated disease following treatment with albendazole 400 mg every 12 hours . Notably the patient was receiving oral prednisone 10 mg once daily azathioprine 50 mg twice daily and hydroxychloroquine 400 mg daily at the time of hospitalization. The patient was .
